Lucid Diagnostics (LUCD) Payables (2020 - 2026)

Lucid Diagnostics' Payables history runs 7 years deep, the most recent figure standing at $26.3 million for Q1 2026.

• Quarterly Payables fell 21.86% year-over-year to $26.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.3 million (down 21.86% YoY) and the FY2025 annual result came in at $25.0 million, up 25.85% from the prior year.
• Payables was $26.3 million for Q1 2026 at Lucid Diagnostics, up from $25.0 million in the prior quarter.
• Across five years, Payables topped out at $33.6 million in Q1 2025 and bottomed at $1.1 million in Q4 2022.
• A 5-year average of $15.2 million and a median of $14.1 million in 2024 frame the typical range for Payables.
• Annual changes were most pronounced in 2022 — Payables decreased 29.13% — and 2023, when it soared 1520.55%.
• Lucid Diagnostics' Payables stood at $1.1 million in 2022, then surged by 1520.55% to $17.1 million in 2023, then climbed by 15.94% to $19.8 million in 2024, then grew by 25.85% to $25.0 million in 2025, then increased by 5.23% to $26.3 million in 2026.
• Business Quant data shows LUCD's Payables at $26.3 million in Q1 2026, $25.0 million in Q4 2025, and $23.1 million in Q3 2025.